177 related articles for article (PubMed ID: 23786015)
1. [Pharmacogenetic criteria of drug-resistant epilepsy].
Oros MM
Lik Sprava; 2012 Dec; (8):71-4. PubMed ID: 23786015
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
[TBL] [Abstract][Full Text] [Related]
3. [Genetic performance criteria for valproate in patients with epilepsy].
Oros MM
Lik Sprava; 2011; (3-4):113-9. PubMed ID: 22416375
[TBL] [Abstract][Full Text] [Related]
4. [The new algorithm for disease management of patients with epilepsy based on genetic research].
Oros MM; Smolanka VI
Lik Sprava; 2012; (1-2):74-81. PubMed ID: 23035603
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of pharmacogenetics on the treatment of epilepsy.
Löscher W; Klotz U; Zimprich F; Schmidt D
Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
[TBL] [Abstract][Full Text] [Related]
7. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
[TBL] [Abstract][Full Text] [Related]
8. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
[TBL] [Abstract][Full Text] [Related]
9. Association between ABCB1 polymorphisms and response to first-generation antiepileptic drugs in a Tunisian epileptic population.
Ajmi M; Boujaafar S; Zouari N; Amor D; Nasr A; Rejeb NB; Amor SB; Omezzine A; Benammou S; Bouslama A
Int J Neurosci; 2018 Aug; 128(8):705-714. PubMed ID: 29198163
[TBL] [Abstract][Full Text] [Related]
10. Association between Genetic Polymorphism of
Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
[No Abstract] [Full Text] [Related]
11. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
[TBL] [Abstract][Full Text] [Related]
12. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
[TBL] [Abstract][Full Text] [Related]
13. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
Bao Y; Liu X; Xiao Z
Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
[TBL] [Abstract][Full Text] [Related]
15. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis.
Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604
[TBL] [Abstract][Full Text] [Related]
16. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients.
Sayyah M; Kamgarpour F; Maleki M; Karimipoor M; Gharagozli K; Shamshiri AR
Epileptic Disord; 2011 Jun; 13(2):155-65. PubMed ID: 21636342
[TBL] [Abstract][Full Text] [Related]
18. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
19. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
[TBL] [Abstract][Full Text] [Related]
20. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
